Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 216,900 | 222,200 | 134,900 | 56,500 | 549,700 |
| Depreciation Amortization | 102,000 | 69,900 | 44,400 | 20,900 | 67,100 |
| Income taxes - deferred | 15,800 | 200 | 100 | -300 | -260,500 |
| Accounts receivable | -75,500 | -90,600 | -54,900 | -14,900 | -142,300 |
| Other Working Capital | -132,000 | -79,000 | -169,800 | -87,400 | -20,800 |
| Other Operating Activity | 315,300 | 214,000 | 134,700 | 53,000 | 282,400 |
| Operating Cash Flow | $442,500 | $336,700 | $89,400 | $27,800 | $475,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,277,100 | -309,000 | -200,900 | -99,700 | -199,000 |
| Net Acquisitions | -30,200 | -31,600 | N/A | N/A | N/A |
| Purchase Of Investment | -2,473,100 | -1,540,200 | -1,171,900 | -802,000 | -3,058,200 |
| Sale Of Investment | N/A | 2,165,300 | 1,628,300 | 790,000 | 2,250,500 |
| Other Investing Activity | 10,100 | -4,500 | -4,500 | -500 | -11,300 |
| Investing Cash Flow | $-216,100 | $280,000 | $251,000 | $-112,200 | $-1,018,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,188,800 |
| Debt Repayment | N/A | N/A | N/A | N/A | -282,600 |
| Common Stock Issued | 20,300 | 20,300 | 8,700 | 8,700 | 15,300 |
| Other Financing Activity | -9,900 | -9,100 | -8,300 | -7,900 | -9,400 |
| Financing Cash Flow | $10,400 | $11,200 | $400 | $800 | $912,100 |
| Exchange Rate Effect | -1,400 | -900 | 100 | -400 | 2,100 |
| Beginning Cash Position | 818,200 | 818,200 | 818,200 | 818,200 | 446,400 |
| End Cash Position | 1,053,600 | 1,445,200 | 1,159,100 | 734,200 | 818,200 |
| Net Cash Flow | $235,400 | $627,000 | $340,900 | $-84,000 | $371,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 442,500 | 336,700 | 89,400 | 27,800 | 475,600 |
| Capital Expenditure | -389,200 | -309,000 | -200,900 | -99,700 | -199,000 |
| Free Cash Flow | 53,300 | 27,700 | -111,500 | -71,900 | 276,600 |